Open Label, Single Dose, Randomized, Crossover Study To Evaluate The Pharmacokinetics And Relative Bioavailability Of Oxycodone Following Oral Administration Of 40 Mg Doses Of PF 00345439 Taken Whole Under Fed Conditions And After Chewing Under Fasted Conditions In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 05 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Nov 2012 New trial record